CoverGirl, NFL partner to offer female fans team-inspired nail looks
HUNT VALLEY, Md. — This fall, football is going femme as Procter & Gamble’s CoverGirl is teaming up with the NFL to celebrate the League’s female fans.
Aside from the team jerseys, lucky hats, foam fingers and pom-poms, women game-goers and –watchers now have the chance to express their on-the-field allegiance via official NFL CoverGirl “fanicures,” inspired by all 32 NFL team logos and colors.
Available online and at retail, the 32 customized CoverGirl Outlast Stay Brilliant Nail Gloss designs offer all women the chance to wear their heart for the home team on their hands, whether a Bengal, Brown, Bronco or Buccaneer.
In addition to the team-customized CoverGirl nail polish designs, NFL fans also will have the opportunity to experience “fanicures” in action at select home games — inside the stadium at NFL Style Lounges and outside the stadium via CoverGirl mobile manicure stations. CoverGirl will encourage fans with a competitive streak to upload their own team-inspired nail looks — going finger-to-finger with rival femmes to rally around their teams via sharing and liking their fellow team posts.
“This unique collaboration will bring new meaning to wearing your team’s colors,” said Rhiannon Madden, the NFL’s director of Apparel. “We are thrilled to be teaming up with CoverGirl to celebrate our female fans with another innovative way to combine their passions for football and style.
Green Smoke E-cigs
Green Smoke® E-Cigs New Packaging and Greater Value
Smokers can now buy a reusable sleek carrying case for their disposables or rechargeables, to enjoy a variety of flavors and nicotine levels that equals up to 2 packs of cigarettes in vapor volume.
With the latest technology for long lasting batteries and the freshness of firmly sealed cartridges, Green Smoke® provides the familiar experience smokers expect. Robust flavors such as Tobacco, Red Tobacco and Menthol provide the variety that smokers are looking for.
Green Smoke® E-Cigs is certainly the brand any retailer serious about their electronic cigarette business should stock. Their proven track record, high retention numbers and unbeatable quality products ensures that customers will continue returning. MSRP: $9.99
For more information call 1-888-636-2618 or visit wholesale.greensmoke.com
Study questions drug-discount programs
NEW YORK — Over the last few years, many drug makers have offered coupons and co-payment-assistance programs as a way to reduce patients’ out-of-pocket spending on medications, but a new study questions whether they really reduce spending in the long run and whether they’re even legal.
The study, conducted by Yale University medical professor Joseph Ross and Harvard University public health professor Aaron Kesselheim and published in the New England Journal of Medicine, analyzed coupons for 374 branded drugs for a variety of conditions listed on InternetDrugCoupons.com. For 8% of the drugs, a cheaper drug that was therapeutically equivalent was available, but for 58% of the other products, there was a generic alternative in the same therapeutic class; in total, 62% of coupons were for branded drugs for which lower-cost alternatives were available.
"The widespread availability of coupons for brand-name pharmaceuticals that can be expected to be used long term and for which lower-cost alternatives are available has important implications for patients," the authors wrote. "Despite the short-term savings achievable with coupons, they do not offset higher long-term costs, because they’re nearly always time-delimited."
Ross and Kesselheim noted that some coupons can be used once, and others more than once, but few could be used for more than a year, and once a program ended, patients would have to pay normal copayments. But by that time, they may have acquired a brand loyalty, and physicians may be slow to switch them to alternatives. In addition, while coupons may reduce out-of-pocket costs for drugs, insurers still had to pay the higher cost.
The authors also cited pending lawsuits against drug manufacturers, alleging that coupons subvert cost-sharing arrangements in patients’ contracts with insurance companies and should be banned as illegal kickbacks.